How does co-trimoxazole interfere with bacterial folate metabolism?

Co-trimoxazole’s sulfamethoxazole competitively inhibits para-aminobenzoic acid utilisation in bacterial dihydrofolate synthesis, while trimethoprim reversibly inhibits bacterial dihydrofolate reductase, preventing conversion to tetrahydrofolate and thereby blocking two consecutive steps needed for purine and nucleic acid synthesis.